Adeno-associated virus-mediated gene transfer for lung diseases

Human Gene Therapy

Volumn 16, Issue 6, 2005, Pages 643-648

  Flotte, Terence R ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; DNA DEPENDENT PROTEIN KINASE; ENZYME INHIBITOR; GENISTEIN; PROTEASOME INHIBITOR; TRANSMEMBRANE CONDUCTANCE REGULATOR; TYRPHOSTIN;

ADENO ASSOCIATED VIRUS; ALPHA 1 ANTITRYPSIN DEFICIENCY; CLINICAL TRIAL; CYSTIC FIBROSIS; DNA TRANSFER; DRUG INHIBITION; ENZYME ACTIVE SITE; ENZYME INHIBITION; GENE TRANSFER; HUMAN; LUNG ALVEOLUS EPITHELIUM; LUNG DISEASE; MUTANT; NONHUMAN; PROTEIN DEGRADATION; PROTEIN DEPHOSPHORYLATION; RECOMBINANT GENE; REVIEW; SEROTYPE; VIRAL GENE THERAPY; VIRUS CAPSID;

ANIMALS; CAPSID; DEPENDOVIRUS; ENZYME INHIBITORS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; LUNG DISEASES; MUTATION; PROTEASOME ENDOPEPTIDASE COMPLEX;

ADENO-ASSOCIATED VIRUS; MIRIDAE;

EID: 20844433393     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2005.16.643     Document Type: Review

References (62)

1. AFIONE, S.A., CONRAD, C.K., KEARNS, W.G., CHUNDURU, S., ADAMS, R., REYNOLDS, T.C., GUGGINO, W.B., CUTTING, G.R., CARTER, B.J., and FLOTTE, T.R. (1996). In vivo model of adeno-associated virus vector persistence and rescue. J. Virol. 70, 3235-3241.
2. AITKEN, M.L., MOSS, R.B., WALTZ, D.A., DOVEY, M.E., TONELLI, M.R., MCNAMARA, S.C., GIBSON, R.L., RAMSEY, B.W., CARTER, B.J., and REYNOLDS, T.C. (2001). A phase I study of aerosolized administration of tgAAVCF to cystic fibrosis subjects with mild lung disease. Hum. Gene Ther. 12, 1907-1916.
3. BECK, S.E., JONES. L.A., CHESNUT, K., WALSH, S.M., REYNOLDS, T.C., CARTER, B.J., ASKIN, F.B., FLOTTE, T.R., and GUGGINO, W.B. (1999). Repeated delivery of adeno-associated virus vectors to the rabbit airway. J. Virol. 73, 9446-9455.
4. BERTRAN, J., YANG, Y., HARGROVE, P., VANIN, E.F., and NIENHUIS, A.W. (1998). Targeted integration of a recombinant globin gene adeno-associated viral vector into human chromosome 19. Ann. N.Y. Acad. Sci. 850, 163-177.
5. BUNING, H., RIED, M.U., PERABO, L., GERNER, P.M., HUTTNER, N.A., ENSSLE, J., and HALLEK, M. (2003). Receptor targeting of adeno-associated virus vectors. Gene Ther. 10, 1142-1151.
6. CHAO, H., LIU, Y., RABINOWITZ, J., LI, C., SAMULSKI, R.J., and WALSH, C.E. (2000). Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors. Mol. Ther. 2, 619-623.
7. CONRAD, C.K., ALLEN, S.S., AFIONE, S.A., REYNOLDS, T.C., BECK, S.E., FEE-MAKI, M., BARRAZZA-ORTIZ, X., ADAMS, R., ASKIN, F.B., CARTER, B.J., GUGGINO, W.B., and FLOTTE, T.R. (1996). Safety of single-dose administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung. Gene Ther. 3, 658-668.
8. DING, W., YAN, Z., ZAK, R., SAAVEDRA, M., RODMAN, D.M., and ENGELHARDT, J.F. (2003). Second-strand genome conversion of adeno-associated virus type 2 (AAV-2) and AAV-5 is not rate limiting following apical infection of polarized human airway epithelia. J. Virol. 77, 7361-7366.
9. DUAN, D., YUE, Y., YAN, Z., and ENGELHARDT, J.F. (2000). A new dual-vector approach to enhance recombinant adeno-associated virus-mediated gene expression through intermolecular cis activation. Nat. Med. 6, 595-598.
10. DUAN, D., YUE, Y., and ENGELHARDT, J.F. (2001). Expanding AAV packaging capacity with trans-splicing or overlapping vectors: A quantitative comparison. Mol. Ther. 4, 383-391.
11. - channels by protein kinase A corrected by insertion of CFTR [see comments]. Nature 358, 581-584.
12. FLOTTE, T.R. (2000). Size does matter: Overcoming the adeno-associated virus packaging limit. Respir. Res. 1, 16-18.
13. FLOTTE, T.R., SOLOW, R., OWENS, R.A., AFIONE, S., ZEITLIN, P.L., and CARTER, B.J. (1992). Gene expression from adeno-associated virus vectors in airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 7, 349-356.
14. FLOTTE, T.R., AFIONE, S.A., CONRAD, C., MCGRATH, S.A., SOLOW, R., OKA, H., ZEITLIN, P.L., GUGGINO, W.B., and CARTER, B.J. (1993a). Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector. Proc. Natl. Acad. Sci. U.S.A. 90, 10613-10617.
15. FLOTTE, T.R., AFIONE, S.A., SOLOW, R., DRUMM, M.L., MARKAKIS, D., GUGGINO, W.B., ZEITLIN, P.L., and CARTER, B.J. (1993b). Expression of the cystic fibrosis transmembrane conductance regulator from a novel adeno-associated virus promoter. J. Biol. Chem. 268, 3781-3790.
16. FLOTTE, T.R., AFIONE, S.A., and ZEITLIN, P.L. (1994). Adeno-associated virus vector gene expression occurs in nondividing cells in the absence of vector DNA integration. Am. J. Respir. Cell Mol. Biol. 11, 517-521.
17. FLOTTE, T., CARTER, B., CONRAD, C., GUGGINO, W., REYNOLDS, T., ROSENSTEIN, B., TAYLOR, G., WALDEN, S., and WETZEL, R. (1996). A phase I study of an adeno-associated virus-CFTR gene vector in adult CF patients with mild lung disease. Hum. Gene Ther. 7, 1145-1159.
18. FLOTTE, T.R., ZEITLIN, P.L., REYNOLDS, T.C., HEALD, A.E., PEDERSEN, P., BECK, S., CONRAD, C.K., BRASS-ERNST, L., HUMPHRIES, M., SULLIVAN, K., WETZEL, R., TAYLOR, G., CARTER, B.J., and GUGGINO, W.B. (2003). Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: A two-part clinical study. Hum. Gene Ther. 14, 1079-1088.
19. 1-antitrypsin (rAAV2-CB-hAAT) gene vector to AAT-deficient adults. Hum. Gene Ther. 15, 93-128.
20. GAO, G.P., ALVIRA, M.R., WANG, L., CALCEDO, R., JOHNSTON, J., and WILSON, J.M. (2002). Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc. Natl. Acad. Sci. U.S.A. 99, 11854-11859.
21. GAO, G., ALVIRA, M.R., SOMANATHAN, S., LU, Y., VANDENBERGHE, L.H., RUX, J.J., CALCEDO, R., SANMIGUEL, J., ABBAS, Z., and WILSON, J.M. (2003). Adeno-associated viruses undergo substantial evolution in primates during natural infections. Proc. Natl. Acad. Sci. U.S.A. 100, 6081-6086.
22. GERARD, C.J., DELL'ARINGA, J., HALE, K.A., and KLUMP, W.M. (2003). A sensitive, real-time, RNA-specific PCR method for the detection of recombinant AAV-CFTR vector expression. Gene Ther. 10, 1744-1753.
23. GIROD, A., RIED, M., WOBUS, C., LAHM, H., LEIKE, K., KLEINSCHMIDT, J., DELAGE, G., and HALLEK, M. (1999). Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2. Nat. Med. 5, 1052-1056.
24. HALBERT, C.L., RUTLEDGE, E.A., ALLEN, J.M., RUSSELL, D.W., and MILLER, A.D. (2000). Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes. J. Virol. 74, 1524-1532.
25. HALBERT, C.L., ALLEN, J.M., and MILLER, A.D. (2001). Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors. J. Virol. 75, 6615-6624.
26. HUTTNER, N.A., GIROD, A., PERABO, L., EDBAUER, D., KLEINSCHMIDT, J.A., BUNING, H., and HALLEK, M. (2003). Genetic modifications of the adeno-associated virus type 2 capsid reduce the affinity and the neutralizing effects of human serum antibodies. Gene Ther. 10, 2139-2147.
27. KALUDOV, N., BROWN, K.E., WALTERS, R.W., ZABNER, J., and CHIORINI, J.A. (2001). Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity. J. Virol. 75, 6884-6893.
28. KEARNS, W.G., AFIONE, S.A., FULMER, S.B., PANG, M.C., ERIKSON, D., EGAN, M., LANDRUM, M.J., FLOTTE, T.R., and CUTTING, G.R. (1996). Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line. Gene Ther. 3, 748-755.
29. KOTIN, R.M., SINISCALCO, M., SAMULSKI, R.J., ZHU, X.D., HUNTER, L., LAUGHLIN, C.A., MCLAUGHLIN, S., MUZYCZKA, N., ROCCHI, M., and BERNS, K.I. (1990). Site-specific integration by adeno-associated virus. Proc. Natl. Acad. Sci. U.S.A. 87, 2211-2215.
30. KOTIN, R.M., MENNINGER, J.C., WARD, D.C., and BERNS, K.I. (1991). Mapping and direct visualization of a region-specific viral DNA integration site on chromosome 19q13-qter. Genomics 10, 831-834.
31. MCCARTY, D.M., MONAHAN, P.E., and SAMULSKI, R.J. (2001). Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis. Gene Ther. 8, 1248-1254.
32. MOSS, R.B., RODMAN, D., SPENCER, L.T., AITKEN, M.L., ZEITLIN, P.L., WALTZ, D., MILLA, C., BRODY, A.S., CLANCY, J.P., RAMSEY, B., HAMBLETT, N., and HEALD, A.E. (2004). Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: A multicenter, double-blind, placebo-controlled trial. Chest 125, 509-521.
33. PERABO, L., BUNING, H., KOFLER, D.M., RIED, M.U., GIROD, A., WENDTNER, C.M., ENSSLE, J., and HALLEK, M. (2003). In vitro selection of viral vectors with modified tropism: The adeno-associated virus display. Mol. Ther. 8, 151-157.
34. PIERONI, L., FIPALDINI, C., MONCIOTTI, A., CIMINI, D., SGURA, A., FATTORI, E., EPIFANO, O., CORTESE, R., PALOMBO, F., and LA MONICA, N. (1998). Targeted integration of adeno-associated virus-derived plasmids in transfected human cells. Virology 249, 249-259.
35. POIRIER, A., CAMPBELL-THOMPSON, M., TANG, Q., SCOTT-JORGENSEN, M., COMBEE, L., LOILER, S., CRAWFORD, J., SONG, S., and FLOTTE, T.R. (2004). Toxicology and biodistribution studies of a recombinant adeno-associated virus 2-α-1 antitrypsin vector. Preclinica 2, 43-51.
36. QING, K., WANG, X.S., KUBE, D.M., PONNAZHAGAN, S., BAJPAI, A., and SRIVASTAVA, A. (1997). Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expression. Proc. Natl. Acad. Sci. U.S.A. 94, 10879-10884.
37. QING, K., KHUNTIRAT, B., MAH, C., KUBE, D.M., WANG, X.S., PONNAZHAGAN, S., ZHOU, S., DWARKI, V.J., YODER, M.C., and SRIVASTAVA, A. (1998). Adeno-associated virus type 2-mediated gene transfer: Correlation of tyrosine phosphorylation of the cellular single-stranded D sequence-binding protein with transgene expression in human cells in vitro and murine tissues in vivo. J. Virol. 72, 1593-1599.
38. QING, K., HANSEN, J., WEIGEL-KELLEY, K.A., TAN, M., ZHOU, S., and SRIVASTAVA, A. (2001). Adeno-associated virus type 2-mediated gene transfer: Role of cellular FKBP52 protein in transgene expression. J. Virol. 75, 8968-8976.
39. RABINOWITZ, J.E., XIAO, W., and SAMULSKI, R.J. (1999). Insertional mutagenesis of AAV2 capsid and the production of recombinant virus. Virology 265, 274-285.
40. SAMULSKI, R.J., ZHU, X., XIAO, X., BROOK, J.D., HOUSMAN, D.E., EPSTEIN, N., and HUNTER, L.A. (1991). Targeted integration of adeno-associated virus (AAV) into human chromosome 19 [published erratum appears in EMBO J. 1992;11:1228]. EMBO J. 10, 3941-3950.
41. SONG, S., MORGAN, M., ELLIS, T., POIRIER, A., CHESNUT, K., WANG, J., BRANTLY, M., MUZYCZKA, N., BYRNE, B.J., ATKINSON, M., and FLOTTE, T.R. (1998). Sustained secretion of human α-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors. Proc. Natl. Acad. Sci. U.S.A. 95, 14384-14388.
42. SONG, S., EMBURY, J., LAIPIS, P.J., BERNS, K.I., CRAWFORD, J.M., and FLOTTE, T.R. (2001a). Stable therapeutic serum levels of human α-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors. Gene Ther. 8, 1299-1306.
43. SONG, S., LAIPIS, P.J., BERNS, K.I., and FLOTTE, T.R. (2001b). Effect of DNA-dependent protein kinase on the molecular fate of the rAAV2 genome in skeletal muscle. Proc. Natl. Acad. Sci. U.S.A. 98, 4084-4088.
44. SONG, S., LU, Y., CHOI, Y.K., HAN, Y., TANG, Q., ZHAO, G., BERNS, K.I., and FLOTTE, T.R. (2004). DNA-dependent PK inhibits adeno-associated virus DNA integration. Proc. Natl. Acad. Sci. U.S.A. 101, 2112-2116.
45. SUMMERFORD, C., and SAMULSKI, R.J. (1998). Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J. Virol. 72, 1438-1445.
46. SUN, L., LI, J., and XIAO, X. (2000). Overcoming adeno-associated virus vector size limitation through viral DNA heterodimerization. Nat. Med. 6, 599-602.
47. SUROSKY, R.T., URABE, M., GODWIN, S.G., MCQUISTON, S.A., KURTZMAN, G.J., OZAWA, K., and NATSOULIS, G. (1997). Adeno-associated virus Rep proteins target DNA sequences to a unique locus in the human genome. J. Virol. 71, 7951-7959.
48. TERAMOTO, S., BARTLETT, J.S., MCCARTY, D., XIAO, X., SAMULSKI, R.I., and BOUCHER, R.C. (1998). Factors influencing adeno-associated virus-mediated gene transfer to human cystic fibrosis airway epithelial cells: Comparison with adenovirus vectors. J. Virol. 72, 8904-8912.
49. TRAPNELL, B.C., CHU, C.S., PAAKKO, P.K., BANKS, T.C., YOSHIMURA, K., FERRANS, V.I., CHERNICK, M.S., and CRYSTAL, R.G. (1991). Expression of the cystic fibrosis transmembrane conductance regulator gene in the respiratory tract of normal individuals and individuals with cystic fibrosis. Proc. Natl. Acad. Sci. U.S.A. 88, 6565-6569.
50. WAGNER, I.A., MORAN, M.L., MESSNER, A.H., DAIFUKU, R., CONRAD, C.K., REYNOLDS, T., GUGGINO, W.B., MOSS, R.B., CARTER, B.I., WINE, I.I., FLOTTE, T.R., and GARDNER, P. (1998a). A phase I/II study of tgAAV-CF for the treatment of chronic sinusitis in patients with cystic fibrosis. Hum. Gene Ther. 9, 889-909.
51. WAGNER, J.A., REYNOLDS, T., MORAN, M.L., MOSS, R.B., WINE, J.J., FLOTTE, T.R., and GARDNER, P. (1998b). Efficient and persistent gene transfer of AAV-CFTR in maxillary sinus [letter]. Lancet 351, 1702-1703.
52. WAGNER, J.A., MESSNER, A.H., MORAN, M.L., DAIFUKU, R., K. KOUYAMA, DESCH, J.K., MANLEY, S., NORBASH, A.M., CONRAD, C.K., FRIBORG, S., REYNOLDS, T., GUGGINO, W.B., MOSS, R.B., CARTER, B.J., WINE, J.J., FLOTTE, T.R., and GARDNER, P. (1999). Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus. Laryngoscope 109, 266-274.
53. WAGNER, J.A., NEPOMUCENO, I.E., MESSNER, A.H., MORAN, M.L., BATSON, E.P., DIMICELI, S., BROWN, B.W., DESCH, J.K., NORBASH, A.M., CONRAD, C.K., GUGGINO, W.B., FLOTTE, T.R,. WINE, J.J., CARTER, B.J., REYNOLDS, T.C., MOSS, R.B., and GARDNER, P. (2002). A phase II, double-bund, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomies. Hum. Gene Ther. 13, 1349-1359.
54. WANG, Z., MA, H.I., LI, J., SUN, L., ZHANG, J., and XIAO, X. (2003). Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo. Gene Ther. 10, 2105-2111.
55. WENDTNER, C.M., KOFLER, D.M., THEISS, H.D., KURZEDER, C., BUHMANN, R., SCHWEIGHOFER, C., PERABO, L., DANHAUSER-RIEDL, S., BAUMERT, J., HIDDEMANN, W., HALLEK, M., and BUNING, H. (2002). Efficient gene transfer of CD40 ligand into primary B-CLL cells using recombinant adeno-associated virus (rAAV) vectors. Blood 100, 1655-1661.
56. WU, P., XIAO, W., CONLON, T., HUGHES, I., AGBANDIE-MCKENNA, M., FERKOL, T., FLOTTE, T., and MUZYCZKA, N. (2000). Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism. J. Virol. 74, 8635-8647.
57. XIE, Q., BU, W., BHATIA, S., HARE, J., SOMASUNDARAM, T., AZZI, A., and CHAPMAN, M.S. (2002). The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy. Proc. Natl. Acad. Sci. U.S.A. 99, 10405-10410.
58. XIE, Q., SOMASUNDARAM, T., BHATIA, S., BU, W., and CHAPMAN, M.S. (2003). Structure determination of adeno-associated virus 2: Three complete virus particles per asymmetric unit. Acta Crystallogr. D Biol. Crystallogr. 59, 959-970.
59. YAN, Z., ZHANG, Y., DUAN, D., and ENGELHARDT, J.F. (2000). From the cover: Trans-splicing vectors expand the utility of adeno-associated virus for gene therapy [see comments]. Proc. Natl. Acad. Sci. U.S.A. 97, 6716-6721.
60. YAN, Z., ZAK, R., LUXTON, G.W., RITCHIE, T.C., BANTELSCHAAL, U., and ENGELHARDT, I.F. (2002). Ubiquitination of both adeno-associated virus type 2 and 5 capsid proteins affects the transduction efficiency of recombinant vectors. J. Virol. 76, 2043-2053.
61. YAN, Z., ZAK, R., ZHANG, Y., DING, W., GODWIN, S., MUNSON, K., PELUSO, R., and ENGELHARDT, J.F. (2004). Distinct classes of proteasome-modulating agents cooperatively augment recombinant adeno-associated virus type 2 and type 5-mediated transduction from the apical surfaces of human airway epithelia. J. Virol. 78, 2863-2874.
62. ZABNER, I., SEILER, M., WALTERS, R., KOTIN, R.M., FULGERAS, W., DAVIDSON, B.L., and CHIORINI, J.A. (2000). Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer. J. Virol. 74, 3852-3858.